Larvol Delta - Zanzalintinib-in-Combination-With-Ipilimumab-and-Nivolumab-in-Patients-With-Metastatic-Soft-Tissue-Sarcoma

zanzalintinib (XL092) - Exelixis

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://clinicaltrials.gov/ct2/show/NCT06968988

Sep 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next